Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation

Cancer Research

Volumn 71, Issue 13, 2011, Pages 4675-4685

  Mayes, Debra A ^a   Rizvi, Tilat A ^a   Cancelas, Jose A ^a,b   Kolasinski, Nathan T ^a   Ciraolo, Georgianne M ^a   Stemmer Rachamimov, Anat O ^c   Ratner, Nancy ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROTROPHIN RECEPTOR P75; PROTEIN S100B; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN CRE; TAMOXIFEN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRAMEDULLARY LYMPHOHEMATOPOIETIC CELL; FEMALE; GANGLION; GENETIC RECOMBINATION; HEMATOPOIETIC CELL; IN VIVO STUDY; MOUSE; NEUROFIBROMATOSIS; NF1 GENE; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; REPORTER GENE; SATELLITE CELL; SCHWANN CELL; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; GENES, NEUROFIBROMATOSIS 1; INTEGRASES; MALE; MICE; MICE, TRANSGENIC; MYELIN PROTEOLIPID PROTEIN; NEUROFIBROMATOSIS 1; TAMOXIFEN;

EID: 79959861743     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-4558     Document Type: Article

References (39)

1. Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999;891:1-6.
2. Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol 2009;611:1-14.
3. Rosenfeld A, Listernick R, Charrow J, Goldman S. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv Syst 2010;265:663-7.
4. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS, et al. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991;77:925-9.
5. Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, et al. Quantitative effects of Nf1 inactivation on in vivo hematopoiesis. Blood 1997;89:3534.
6. Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP, et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type1. Blood 1998;92:267-72.
7. Woodruff JM. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet 1999;891:23-30.
8. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, et al. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 1997;61:512-9.
9. Serra E, Ars E, Ravella A, Sánchez A, Puig S, Rosenbaum T, et al. Somatic NF1 mutational spectrum in benign neurofibromas; mRNA splice defects are common among point mutations. Hum Genet 2001;108:416-29.
10. Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T, et al. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 2006;27:1030-40.
11. Dong Z, Sinanan A, Parkinson D, Parmantier E, Mirsky R, Jessen KR, et al. Schwann cell development in embryonic mouse nerves. J Neurosci Res 1999;56:334-48.
12. Jessen KR, Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev 2005;6:671-82.
13. Bixby S, Kruger GM, Mosher JT, Joseph NM, Morrison SJ, et al. Cellintrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 2002;35:643-56.
14. Joseph NM, Mosher JT, Buchstaller J, Snider P, McKeever PE, Lim M, et al. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 2008;132: 129-40.
15. Kléber M, Lee HY, Wurdak H, Buchstaller J, Riccomagno MM, Ittner LM, et al. Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling. J Cell Biol 2005;169:309-20.
16. Morrison SJ, White PM, Zock C, Anderson DJ. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999;965:737-49.
17. Nagoshi N, Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad Cell Stem. Cell 2008;2:392-403.
18. Mirsky R, Woodhoo A, Parkinson DB, Arthur-Farraj P, Bhaskaran A, Jessen KR, et al. Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiation. J Peripheral Nerv Syst 2008;13:122-35.
19. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994;8:1019-29.
20. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994;7:353-61.
21. Gitler AD, Zhu Y, Ismat FA, Lu MM, Yamauchi Y, Parada LF, et al. Nf1 has an essential role in endothelial cells. Nat Genet 2003;331:75-9.
22. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF, et al. Neurofibromas in NF1; Schwann cell origin and role of tumor environment. Science 2002;296:920-2.
23. Zheng H, Chang L, Patel N, Yang J, Lowe L, Burns DK, et al. Induction of abnormal proliferation by nonmyelinating Schwann cells triggers neurofibroma formation. Cancer Cell 2008;13:117-28.
24. Wu J, Williams JP, Rizvi TA, Kordich JJ, Witte D, Meijer D, et al. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 2008;13:105-16.
25. Mallon BS, Shick HE, Kidd GJ, Macklin WB. Proteolipid Promoter Activity Distinguishes Two Populations of NG2-Positive Cells throughout Neonatal Cortical Development. J Neurosci 2002;22:876-85.
26. Doerflinger NH, Macklin WB, Popko B. Inducible site-specific recombination in myelinating cells. Genesis 2003;35:63-72.
27. Nakamura T, Colbert MC, Robbins J. Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system. Circ Res 2006;9812:1547-54.
28. Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, et al. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res 2004;64:3718-24.
29. Feng JM, Fernandes AO, Bongarzone ER, Campagnoni CW, Kampf K, Campagnoni AT, et al. Expression of soma-restricted proteolipid/ DM20 proteins in lymphoid cells. J Neuroimmunol 2003;144:9-15.
30. Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009;20611:2483-96.
31. Gao J, Yan XL, Li R, Liu Y, He W, Sun S, et al. Characterization of OP9 as authentic mesenchymal stem cell line. J Genet Genomics 2010;377:475-82.
32. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ, et al. Adult stem cells from bone marrow MSCs isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-8.
33. Gupta SK, Pringle J, Poduslo JF, Mezei C. Levels of proteolipid protein mRNAs in peripheral nerve are not under stringent axonal control. J Neurochem 1991;56:1754-62.
34. Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, et al. Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis. Cancer Cell 2005;71:65-75.
35. Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, et al. Nf1-deficient tumors require a microenvironment containing Nf1+/- and c-kit-dependent bond marrow. Cell 2008;1353:437-48.
36. Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, et al. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 2004;103:4243-50.
37. Zhang Y, Taylor BR, Shannon K, Clapp DW. Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin. J Clin Invest 2001;1085:709-15.
38. Kim TJ, Cariappa A, Iacomini J, Tang M, Shih S, Bernards A, et al. Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin. Mol Immunol 2002;389:701-8.
39. Chan CK, Chen CC, Luppen CA, Kim JB, DeBoer AT, Wei K, et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 2009;457:490-4.